Back to results
US 2014/0275106 A1Published application
Combinations of akt inhibitor compounds and vemurafenib, and methods of use
AssigneeGenentech, Inc.
InventorsKlaus Hoeflich, Mark Merchant
Life of this patent
Estimating the term…
Abstract
The invention provides a combination of a) a compound of Formula Ia: [insert Formula Ia], or a pharmaceutically acceptable salt thereof, and b) vemurafenib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer.
Claims15
A combination of a) a compound of Formula Ia:
- or a pharmaceutically acceptable salt thereof, and b) vemurafenib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder.
Dependencies are inferred from the claim text.